Imunon, Inc. Research and Development Expense
Imunon, Inc. (IMNN) reported Research and Development Expense of $1.46 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-11
- Imunon, Inc. research and development expense for the quarter ending 2026-06-30 was $1.46M, a 19.37% increase year-over-year.
- Imunon, Inc. research and development expense for the quarter ending 2026-03-31 was $2.34M, a 7.95% increase year-over-year.
- Imunon, Inc. research and development expense for the quarter ending 2025-12-31 was $2.49M, a 11.50% increase year-over-year.
- Imunon, Inc. research and development expense for the quarter ending 2025-09-30 was $1.90M, a 42.33% decline year-over-year.
- Imunon, Inc. research and development expense for fiscal 2025 was $7.78M, a 33.15% decline from fiscal 2024.
- Imunon, Inc. research and development expense for fiscal 2024 was $11.64M, a 3.12% increase from fiscal 2023.
- Imunon, Inc. research and development expense for fiscal 2023 was $11.29M, a 3.80% decline from fiscal 2022.
- Imunon, Inc. research and development expense for fiscal 2022 was $11.73M, a 10.49% increase from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $1.46M 10-Q · filed 2026-08-11 | $3.80M 10-Q · filed 2026-08-11 | $6.29M derived: sum of 3 quarters · filed 2026-08-11 | $8.19M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $2.34M 10-Q · filed 2026-05-12 | $4.83M derived: sum of 2 quarters · filed 2026-05-12 | $6.73M derived: sum of 3 quarters · filed 2026-05-12 | $7.95M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $2.49M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $4.39M derived: sum of 2 quarters · filed 2026-03-31 | $5.62M derived: sum of 3 quarters · filed 2026-08-11 | $7.78M 10-K · filed 2026-03-31 | |
| 2025-09-30 | $1.90M 10-Q · filed 2025-11-13 | $3.13M derived: sum of 2 quarters · filed 2026-08-11 | $5.29M 10-Q · filed 2025-11-13 | $7.52M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $1.23M 10-Q · filed 2026-08-11 | $3.39M 10-Q · filed 2026-08-11 | $5.62M derived: sum of 3 quarters · filed 2026-08-11 | $8.92M derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $2.17M 10-Q · filed 2026-05-12 | $4.40M derived: sum of 2 quarters · filed 2026-05-12 | $7.69M derived: sum of 3 quarters · filed 2026-05-12 | $10.51M derived: sum of 4 quarters · filed 2026-05-12 | |
| 2024-12-31 | $2.23M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $5.53M derived: sum of 2 quarters · filed 2026-03-31 | $8.35M derived: sum of 3 quarters · filed 2026-03-31 | $11.64M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $3.29M 10-Q · filed 2025-11-13 | $6.11M derived: sum of 2 quarters · filed 2025-11-13 | $9.41M 10-Q · filed 2025-11-13 | $12.96M derived: sum of 4 quarters · filed 2025-11-13 | |
| 2024-06-30 | $2.82M 10-Q · filed 2025-08-05 | $6.11M 10-Q · filed 2025-08-05 | $9.67M derived: sum of 3 quarters · filed 2025-08-05 | $11.65M derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-03-31 | $3.29M 10-Q · filed 2025-05-12 | $6.85M derived: sum of 2 quarters · filed 2025-05-12 | $8.83M derived: sum of 3 quarters · filed 2025-05-12 | $11.96M derived: sum of 4 quarters · filed 2025-05-12 | |
| 2023-12-31 | $3.55M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.53M derived: sum of 2 quarters · filed 2025-02-27 | $8.67M derived: sum of 3 quarters · filed 2025-02-27 | $11.29M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $1.98M 10-Q · filed 2024-11-07 | $5.12M derived: sum of 2 quarters · filed 2024-11-07 | $7.73M 10-Q · filed 2024-11-07 | $10.74M derived: sum of 4 quarters · filed 2024-11-07 | |
| 2023-06-30 | $3.13M 10-Q · filed 2024-08-14 | $5.75M 10-Q · filed 2024-08-14 | $8.76M derived: sum of 3 quarters · filed 2024-08-14 | $11.17M derived: sum of 4 quarters · filed 2024-08-14 | |
| 2023-03-31 | $2.62M 10-Q · filed 2024-05-13 | $5.62M derived: sum of 2 quarters · filed 2024-05-13 | $8.03M derived: sum of 3 quarters · filed 2024-05-13 | $11.26M derived: sum of 4 quarters · filed 2024-05-13 | |
| 2022-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $5.41M derived: sum of 2 quarters · filed 2024-03-28 | $8.64M derived: sum of 3 quarters · filed 2024-03-28 | $11.73M 10-K · filed 2024-03-28 | |
| 2022-09-30 | $2.41M 10-Q · filed 2023-11-14 | $5.63M derived: sum of 2 quarters · filed 2023-11-14 | $8.73M 10-Q · filed 2023-11-14 | $11.72M derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $3.23M 10-Q · filed 2023-08-10 | $6.32M 10-Q · filed 2023-08-10 | $9.31M derived: sum of 3 quarters · filed 2023-08-10 | $11.78M derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | $3.10M 10-Q · filed 2023-05-11 | $6.08M derived: sum of 2 quarters · filed 2023-05-11 | $8.55M derived: sum of 3 quarters · filed 2023-05-11 | $11.14M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $5.45M derived: sum of 2 quarters · filed 2023-03-30 | $8.05M derived: sum of 3 quarters · filed 2023-03-30 | $10.62M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $2.47M 10-Q · filed 2022-11-14 | $5.06M derived: sum of 2 quarters · filed 2022-11-14 | $7.63M 10-Q · filed 2022-11-14 | $10.44M derived: sum of 4 quarters · filed 2022-11-14 | |
| 2021-06-30 | $2.59M 10-Q · filed 2022-08-15 | $5.16M 10-Q · filed 2022-08-15 | $7.98M derived: sum of 3 quarters · filed 2022-08-15 | $10.47M derived: sum of 4 quarters · filed 2022-08-15 | |
| 2021-03-31 | $2.57M 10-Q · filed 2022-05-16 | $5.38M derived: sum of 2 quarters · filed 2022-05-16 | $7.87M derived: sum of 3 quarters · filed 2022-05-16 | $10.86M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $2.81M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | $5.30M derived: sum of 2 quarters · filed 2022-03-31 | $8.29M derived: sum of 3 quarters · filed 2022-03-31 | $11.34M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $2.49M 10-Q · filed 2021-11-15 | $5.48M derived: sum of 2 quarters · filed 2021-11-15 | $8.53M 10-Q · filed 2021-11-15 | $11.60M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $2.99M 10-Q · filed 2021-08-12 | $6.04M 10-Q · filed 2021-08-12 | $9.11M derived: sum of 3 quarters · filed 2021-08-12 | $12.78M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $3.05M 10-Q · filed 2021-05-14 | $6.12M derived: sum of 2 quarters · filed 2021-05-14 | $9.79M derived: sum of 3 quarters · filed 2021-05-14 | $13.35M derived: sum of 4 quarters · filed 2021-05-14 | |
| 2019-12-31 | $3.07M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-19 | $6.74M derived: sum of 2 quarters · filed 2021-03-19 | $10.30M derived: sum of 3 quarters · filed 2021-03-19 | $13.07M 10-K · filed 2021-03-19 | |
| 2019-09-30 | $3.67M 10-Q · filed 2020-11-16 | $7.23M derived: sum of 2 quarters · filed 2020-11-16 | $10.00M 10-Q · filed 2020-11-16 | $12.34M derived: sum of 4 quarters · filed 2020-11-16 | |
| 2019-06-30 | $3.56M 10-Q · filed 2020-08-14 | $6.33M 10-Q · filed 2020-08-14 | $8.67M derived: sum of 3 quarters · filed 2020-08-14 | $10.86M derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | $2.77M 10-Q · filed 2020-05-15 | $5.11M derived: sum of 2 quarters · filed 2020-05-15 | $7.30M derived: sum of 3 quarters · filed 2020-05-15 | $11.89M derived: sum of 4 quarters · filed 2020-05-15 | |
| 2018-12-31 | $2.34M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | $4.53M derived: sum of 2 quarters · filed 2020-03-25 | $9.12M derived: sum of 3 quarters · filed 2020-03-25 | $11.87M 10-K · filed 2020-03-25 | |
| 2018-09-30 | $2.19M 10-Q · filed 2019-11-14 | $6.78M derived: sum of 2 quarters · filed 2019-11-14 | $9.52M 10-Q · filed 2019-11-14 | $12.73M derived: sum of 4 quarters · filed 2019-11-14 | |
| 2018-06-30 | $4.59M 10-Q · filed 2019-08-14 | $7.33M 10-Q · filed 2019-08-14 | $10.54M derived: sum of 3 quarters · filed 2019-08-14 | $13.89M derived: sum of 4 quarters · filed 2019-08-14 | |
| 2018-03-31 | $2.74M 10-Q · filed 2019-05-15 | $5.95M derived: sum of 2 quarters · filed 2019-05-15 | $9.30M derived: sum of 3 quarters · filed 2019-05-15 | $12.65M derived: sum of 4 quarters · filed 2019-05-15 | |
| 2017-12-31 | $3.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $6.56M derived: sum of 2 quarters · filed 2019-03-29 | $9.91M derived: sum of 3 quarters · filed 2019-03-29 | $13.08M 10-K · filed 2019-03-29 | |
| 2017-09-30 | $3.35M 10-Q · filed 2017-11-14 | $6.70M derived: sum of 2 quarters · filed 2018-11-14 | $9.87M 10-Q · filed 2018-11-14 | $13.79M derived: sum of 4 quarters · filed 2018-11-14 | |
| 2017-06-30 | $3.35M 10-Q · filed 2018-11-14 | $3.05M 10-Q · filed 2017-08-14 | $6.52M 10-Q · filed 2018-08-14 | $10.44M derived: sum of 3 quarters · filed 2018-11-14 | $14.67M derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-03-31 | $3.48M 10-Q · filed 2018-05-11 | $7.10M derived: sum of 2 quarters · filed 2018-05-11 | $11.32M derived: sum of 3 quarters · filed 2018-05-11 | $14.66M derived: sum of 4 quarters · filed 2018-05-11 | |
| 2016-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-27 | $7.85M derived: sum of 2 quarters · filed 2018-03-27 | $11.18M derived: sum of 3 quarters · filed 2018-03-27 | $14.62M 10-K · filed 2018-03-27 | |
| 2016-09-30 | $4.23M 10-Q · filed 2017-11-14 | $7.56M derived: sum of 2 quarters · filed 2017-11-14 | $11.00M 10-Q · filed 2017-11-14 | $14.71M derived: sum of 4 quarters · filed 2017-11-14 | |
| 2016-06-30 | $3.34M 10-Q · filed 2017-08-14 | $6.78M 10-Q · filed 2017-08-14 | $10.48M derived: sum of 3 quarters · filed 2017-08-14 | $13.36M derived: sum of 4 quarters · filed 2017-08-14 | |
| 2016-03-31 | $3.44M 10-Q · filed 2017-05-12 | $7.14M derived: sum of 2 quarters · filed 2017-05-12 | $10.03M derived: sum of 3 quarters · filed 2017-05-12 | $13.59M derived: sum of 4 quarters · filed 2017-05-12 | |
| 2015-12-31 | $3.70M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-24 | $6.59M derived: sum of 2 quarters · filed 2017-03-24 | $10.15M derived: sum of 3 quarters · filed 2017-03-24 | $14.66M 10-K · filed 2017-03-24 | |
| 2015-09-30 | $2.88M 10-Q · filed 2016-11-10 | $6.45M derived: sum of 2 quarters · filed 2016-11-10 | $10.96M 10-Q · filed 2016-11-10 | $15.24M derived: sum of 4 quarters · filed 2016-11-10 | |
| 2015-06-30 | $3.57M 10-Q · filed 2016-08-15 | $8.07M 10-Q · filed 2016-08-15 | $12.36M derived: sum of 3 quarters · filed 2016-08-15 | $16.98M derived: sum of 4 quarters · filed 2016-08-15 | |
| 2015-03-31 | $4.51M 10-Q · filed 2016-05-16 | $8.79M derived: sum of 2 quarters · filed 2016-05-16 | $13.42M derived: sum of 3 quarters · filed 2016-05-16 | $16.58M derived: sum of 4 quarters · filed 2016-05-16 | |
| 2014-12-31 | $4.28M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $8.91M derived: sum of 2 quarters · filed 2016-03-30 | $12.08M derived: sum of 3 quarters · filed 2016-03-30 | $14.97M 10-K · filed 2016-03-30 | |
| 2014-09-30 | $4.63M 10-Q · filed 2015-11-05 | $7.80M derived: sum of 2 quarters · filed 2015-11-05 | $10.69M 10-Q · filed 2015-11-05 | $12.56M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-06-30 | $3.17M 10-Q · filed 2015-08-10 | $6.06M 10-Q · filed 2015-08-10 | $7.93M derived: sum of 3 quarters · filed 2016-03-30 | $10.20M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2014-03-31 | $2.89M 10-Q · filed 2015-05-11 | $4.76M derived: sum of 2 quarters · filed 2016-03-30 | $7.03M derived: sum of 3 quarters · filed 2016-03-30 | $9.05M derived: sum of 4 quarters · filed 2016-03-30 | |
| 2013-12-31 | $1.87M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-30 | $4.14M derived: sum of 2 quarters · filed 2016-03-30 | $6.16M derived: sum of 3 quarters · filed 2016-03-30 | $9.36M 10-K · filed 2016-03-30 | |
| 2013-09-30 | $2.27M 10-Q · filed 2014-11-10 | $4.29M derived: sum of 2 quarters · filed 2014-11-10 | $7.49M 10-Q · filed 2014-11-10 | $10.92M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $2.02M 10-Q · filed 2014-08-07 | $5.23M 10-Q · filed 2014-08-07 | $8.65M derived: sum of 3 quarters · filed 2015-03-12 | $12.19M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $3.20M 10-Q · filed 2014-05-08 | $6.63M derived: sum of 2 quarters · filed 2015-03-12 | $10.17M derived: sum of 3 quarters · filed 2015-03-12 | $14.28M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2012-12-31 | $3.43M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $6.96M derived: sum of 2 quarters · filed 2015-03-12 | $11.08M derived: sum of 3 quarters · filed 2015-03-12 | $15.77M 10-K · filed 2015-03-12 | |
| 2012-09-30 | $3.54M 10-Q · filed 2013-11-12 | $7.65M derived: sum of 2 quarters · filed 2013-11-12 | $12.34M 10-Q · filed 2013-11-12 | $17.48M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-06-30 | $4.11M 10-Q · filed 2013-08-08 | $8.81M 10-Q · filed 2013-08-08 | $13.94M derived: sum of 3 quarters · filed 2014-03-13 | $19.36M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2012-03-31 | $4.69M 10-Q · filed 2013-05-09 | $9.83M derived: sum of 2 quarters · filed 2014-03-13 | $15.24M derived: sum of 3 quarters · filed 2014-03-13 | $20.21M derived: sum of 4 quarters · filed 2014-03-13 | |
| 2011-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13 | $10.55M derived: sum of 2 quarters · filed 2014-03-13 | $15.52M derived: sum of 3 quarters · filed 2014-03-13 | $19.86M 10-K · filed 2014-03-13 | |
| 2011-09-30 | $5.41M 10-Q · filed 2012-11-09 | $10.38M derived: sum of 2 quarters · filed 2012-11-09 | $14.73M 10-Q · filed 2012-11-09 | $18.78M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-06-30 | $4.96M 10-Q · filed 2012-08-14 | $9.31M 10-Q · filed 2012-08-14 | $13.36M derived: sum of 3 quarters · filed 2013-03-18 | $17.31M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2011-03-31 | $4.35M 10-Q · filed 2012-05-15 | $8.40M derived: sum of 2 quarters · filed 2013-03-18 | $12.35M derived: sum of 3 quarters · filed 2013-03-18 | $15.79M derived: sum of 4 quarters · filed 2013-03-18 | |
| 2010-12-31 | $4.05M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-18 | $8.00M derived: sum of 2 quarters · filed 2013-03-18 | $11.44M derived: sum of 3 quarters · filed 2013-03-18 | $14.71M 10-K · filed 2013-03-18 | |
| 2010-09-30 | $3.95M 10-Q · filed 2011-11-10 | $7.39M derived: sum of 2 quarters · filed 2011-11-10 | $10.67M 10-Q · filed 2011-11-10 | ||
| 2010-06-30 | $3.44M 10-Q · filed 2011-08-09 | $6.71M 10-Q · filed 2011-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |